Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-28 @ 2:46 PM
Study NCT ID:
NCT04613466
Status:
UNKNOWN
Last Update Posted:
2020-11-13
First Post:
2020-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease
Sponsor:
Assiut University
Organization:
Study Overview
Official Title:
The Prevelance of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease
Status:
UNKNOWN
Status Verified Date:
2020-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Bronchopulmonary manifestations signs and symptoms are variable extraintestinal manifestations of IBD.
Detailed Description:
Several cases like bronchiactsis, bronchitis, tracheobronchitis and broncholitis. None of this complications are specific for either crohns or ulcerative , however the majority of cases are related to ulcerative colitis.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: